Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1275 of 5804
-
Could a cream help control Early-Stage skin lymphoma?
Disease control Recruiting nowTo study the safety and effectiveness of tofacitinib 2% cream in treating early-stage CTCL.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a smartphone app and a coach help young sickle cell patients hurt less?
Symptom relief Recruiting nowThe study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs …
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New toolkit aims to stop mental health problems before they start in military airmen
Prevention Recruiting nowSub-clinical behavioral health services in the military are performed by BH technicians, who receive minimal training. Due to this, embedding more technicians in military units is unlikely to benefit service members. Giving technicians training in, and access to, evidence-based i…
Phase: NA • Sponsor: New York University • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
Nerve pain drug duloxetine tested to stop pancreatitis after ERCP
Prevention Recruiting nowEndoscopic retrograde cholangiopancreatography (ERCP (, a key tool that is used in diagnosis and treatment of pancreato-biliary diseases. Post-ERCP pancreatitis (PEP) is the most common and serious complication that can occur following this procedure and can lead to significant m…
Phase: PHASE3 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New device SWM-831 tackles hardened leg arteries in japanese study
Disease control OngoingDisrupt PAD Japan is a prospective, multi-center, single-arm study of SWM-831 to treat moderate and severely calcified femoropopliteal arteries, prior to DCB or stenting.
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Light-Based device could predict chemo success in breast cancer
Diagnosis Recruiting nowThe purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy (NAC).
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New hope for kidney transplant patients facing rejection
Disease control Recruiting nowThe primary objective of this study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with active or chronic active antibody-mediated rejection (AMR) at Week 52.
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI therapist in virtual reality aims to treat depression
Symptom relief Recruiting nowDepression is a prevalent mental disorder characterized by pervasive low mood, diminished interest or pleasure, and a range of cognitive and physical symptoms. According to the World Health Organization (WHO), depression is a leading cause of disability worldwide, affecting appro…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 26, 2026 17:07 UTC
-
New weight loss pill shows promise in early trial
Disease control CompletedThis is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Phase: PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
One shot of methadone during surgery could slash opioid prescriptions
Symptom relief Recruiting nowCurrently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term o…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Steroids may ease painful skin side effect of breast cancer chemo
Symptom relief Recruiting nowInvestigating the Association Between Corticosteroid Use and Improvement in Doxorubicin Liposome-Induced Cutaneous Toxicity: Exploring the Feasibility and Mechanisms of Corticosteroids in Mitigating Liposomal Doxorubicin-Related Dermatologic Adverse Effects.
Phase: PHASE3 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New ultrasound technique could spot breast cancer without a needle
Diagnosis Recruiting nowPurpose: This study will evaluate how measurements of tissue stiffness, viscosity, and anisotropy using non-invasive ultrasound imaging correlate with breast tumor malignancy and response to chemotherapy. Participants: Up to 200 women with benign or malignant breast tumors for a…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Video and alert system aims to boost lifesaving heart failure prescriptions
Disease control Recruiting nowAn increasing number of guideline-directed medical therapies (GDMT) have been developed for patients with chronic heart failure with reduced ejection fraction (HFrEF). When used in combination at recommended doses, patients often experience significant improvements in cardiac fun…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New trial aims to customize breast cancer radiation to cut harmful side effects
Disease control Recruiting nowOur objective is based on a personalized approach of adjuvant breast radiotherapy by selecting patients according to tumor recurrence and toxicity risk.
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for rare cancers: first human trial of ANS03 begins
Disease control Recruiting nowThis is a first-in-human Phase I, multi-center, open-label study of ANS03 in patients with advanced solid tumors. The study evaluates the safety, tolerability, preliminary efficay, pharmacokinetics, anti-tumor activity of ANS03 as monotherapy.
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart failure recovery: time to cut the pills?
Disease control Recruiting nowStudy start date is on Nov 27th 2024. A patient with an initial ejection fraction (EF) of less than 40%, whose follow-up shows an improvement to an EF of 50% or higher, along with the left ventricular end-diastolic diameter returning to the normal range and taking 3 more heart f…
Phase: NA • Sponsor: Chungnam National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Weight-Loss drug added to arthritis therapy shows promise in new trial
Disease control Recruiting nowThe main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Steroid shot could ease knee pain without surgery
Symptom relief Recruiting nowThe value of corticosteroid infiltration of the meniscus wall in the therapeutic strategy is not clearly defined: the data in the literature on the effectiveness of corticosteroid infiltration are heterogeneous and of low level of proof. We hypothesize that corticosteroid infiltr…
Phase: PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo aims to protect kidney transplants from early failure
Disease control OngoingProspective double blind randomized controlled trial. By randomizing patients undergoing kidney transplantation into a conventional catecholamine drug (dobutamine) blood pressure maintenance group and a terlipressin-complexed dobutamine group, the investigators compared the effec…
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New belly pain test could save kids from unnecessary hospital trips
Diagnosis Recruiting nowBACKGROUND Acute appendicitis (AA) in an early stage is difficult to distinguish from other (self-limiting) causes of acute abdominal pain (e.g. constipation and gastroenteritis), resulting in missing 19% of children with AA at first presentation in primary care and 70% of non-AA…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC